A recent study reported that EGFR positive expression assessed by IHC in NSCLC was associated with better survival in patients receiving EGFR TKI [31], which was contrasted to our study that EGFR positivity predicted for worse survival in patients treated with radiotherapy. This evidence concerns the gene EGFR and non-small cell lung carcinoma.